GRAFALON, Infusionslösungskonzentrat

7680524120021 CH-52412 Infusionslösungskonzentrat
GRAFALON, Infusionslösungskonzentrat
GRAFALON, Infusionslösungskonzentrat
GRAFALON, Infusionslösungskonzentrat
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
Durchstechflasche(n)
Galenic form
Infusionslösungskonzentrat
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/08/2025
Summary of Product Characteristics
Français
06/08/2025
Summary of Product Characteristics
Italien
06/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 4060.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2025

Authorization holder

Neovii Pharmaceuticals AG

None Rapperswil-Jona

Authorization information

Swissmedic authorization number
52412
Drug name
GRAFALON, Infusionslösungskonzentrat
Galenic form
LSPA
ATC Code
L04AA04
Authorization status
Z
Dispensing category
B
First authorization
16/06/1994
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Prophylaxe und Therapie von Abstossungskrisen nach Transplantationen

Package details

Description (FR)
GRAFALON conc perf 100 mg/5ml 10 flac 5 ml
Description (DE)
GRAFALON Inf Konz 100 mg/5ml 10 Durchstf 5 ml
Market launch
23/05/1996
Narcotic (BTM)
No

Application methods

IV

Other package sizes (5)

GRAFALON conc perf 100 mg/5ml flac 5 ml
1 DUR
GTIN: 7680524120014
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1